Srivastava Kamal D, Qu Chunfeng, Zhang Tengfei, Goldfarb Joseph, Sampson Hugh A, Li Xiu-Min
Department of Pediatrics, Jaffe Food Allergy Institute, Mount Sinai School of Medicine, New York, NY, USA.
J Allergy Clin Immunol. 2009 Feb;123(2):443-51. doi: 10.1016/j.jaci.2008.12.1107.
Food allergy is a serious and sometimes fatal condition for which there is no cure. We previously reported that Food Allergy Herbal Formula (FAHF)-2) protected peanut-allergic mice against anaphylactic reactions as long as 4 weeks posttherapy. This formula is now in clinical trials in the United States.
We sought to determine whether FAHF-2-mediated protection could be extended long-term and explored the mechanisms underlying its persistent immunomodulatory effects.
Peanut-allergic mice received FAHF-2 daily orally by gavage for 7 weeks, and then received 7 oral peanut challenges at intervals of 4 to 10 weeks over a period of 36 weeks. For mechanistic studies, some mice received CD4(+) or CD8(+) T-cell-depleting antibodies or IFN-gamma-neutralizing antibodies. Anaphylactic symptoms, body temperatures, and plasma histamine levels were recorded after each challenge, and peanut-specific immunoglobulin levels and cytokine profiles of splenocytes, mesenteric lymph node cells, and purified CD4(+) and CD8(+) T cells were determined.
Food Allergy Herbal Formula-2 treatment protected mice from anaphylaxis for more than 36 weeks after discontinuing treatment. Peanut-specific IgE levels were reduced as much as 50%, whereas IgG(2a) levels were increased as much as 60%, and these effects persisted over time. T(H)2 cytokine production by CD4(+) T cells from FAHF-2-treated mice was reduced as much as 75%, whereas CD8(+) T-cell IFN-gamma production was markedly increased by as much as 85% at the final challenge. Neutralization of INF-gamma and depletion of CD8(+) T cells markedly attenuated FAHF-2 efficacy.
Food Allergy Herbal Formula-2 provides long-term protection from anaphylaxis by inducing a beneficial shift in allergen-specific immune responses mediated largely by elevated CD8(+) T-cell IFN-gamma production.
食物过敏是一种严重且有时会致命的疾病,目前尚无治愈方法。我们之前报道过食物过敏草药配方(FAHF)-2可保护花生过敏小鼠在治疗后长达4周内免受过敏反应影响。该配方目前正在美国进行临床试验。
我们试图确定FAHF-2介导的保护作用是否能长期维持,并探究其持续免疫调节作用的潜在机制。
花生过敏小鼠每天经口灌胃给予FAHF-2,持续7周,然后在36周内每隔4至10周接受7次口服花生激发试验。为进行机制研究,部分小鼠接受CD4(+)或CD8(+) T细胞耗竭抗体或IFN-γ中和抗体。每次激发试验后记录过敏症状、体温和血浆组胺水平,并测定花生特异性免疫球蛋白水平以及脾细胞、肠系膜淋巴结细胞和纯化的CD4(+)和CD8(+) T细胞的细胞因子谱。
停止治疗后,食物过敏草药配方-2治疗可保护小鼠超过36周免受过敏反应影响。花生特异性IgE水平降低多达50%,而IgG(2a)水平升高多达60%,且这些作用随时间持续存在。FAHF-2治疗小鼠的CD4(+) T细胞产生的T(H)2细胞因子减少多达75%,而在末次激发试验时CD8(+) T细胞产生的IFN-γ显著增加多达85%。中和IFN-γ以及耗竭CD8(+) T细胞可显著减弱FAHF-2的疗效。
食物过敏草药配方-2通过诱导过敏原特异性免疫反应发生有益转变,主要由升高的CD8(+) T细胞IFN-γ产生介导,从而提供长期的过敏反应保护。